NCT07472322 2026-03-16
ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1
University of Wisconsin, Madison
Phase 1/2 Not yet recruiting
Clinical Trials
1 trialsNot yet recruiting × Carcinoma, Merkel Cell × decitabine and cedazuridine drug combination × Clear all